Skip to main content

TYENNE

NDC 65219-584 · Fresenius Kabi USA, LLC

Generic nameTocilizumab-aazg
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)TOCILIZUMAB
Strength162 mg/.9mL
Pharmacologic classInterleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]
Marketing categoryBLA

Packages

65219-584-01 — 1 SYRINGE, GLASS in 1 CARTON (65219-584-01) / .9 mL in 1 SYRINGE, GLASS

Billed under HCPCS

Q5135 — Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg Medicare Part B payment limit (ASP + 6%): $4.06

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50242-135 — tocilizumab, 50242-136 — tocilizumab, 50242-137 — tocilizumab, 50242-138 — tocilizumab, 50242-143 — tocilizumab, 64406-022 — Tocilizumab, 64406-023 — Tocilizumab, 64406-024 — Tocilizumab, 65219-586 — Tocilizumab-aazg, 65219-590 — Tocilizumab-aazg, 65219-592 — Tocilizumab-aazg, 65219-594 — Tocilizumab-aazg, 65219-596 — Tocilizumab-aazg, 65219-598 — Tocilizumab-aazg, 72606-042 — tocilizumab, 72606-043 — tocilizumab, 72606-044 — tocilizumab, 72606-045 — tocilizumab, 78206-200 — TOCILIZUMAB, 78206-201 — TOCILIZUMAB, +1 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.